International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
www.ijsr.net | Most Trusted Research Journal Since Year 2012

ISSN: 2319-7064



Research Paper | Oncology Science | Egypt | Volume 6 Issue 9, September 2017

Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid

Background The aim of this study is to compare the efficacy and the safety of docetaxel, doxorubicin and cyclophosphamide (TAC) with 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) as adjuvant treatment for early stage node positive breast cancer patients. Methods Sixty patients with pathologically confirmed early stage node-positive breast cancer were randomly assigned to receive six cycles of eitherdocetaxel (75mg/m), doxorubicin (50mg/m) and cyclophosphamide (500mg/m) every three weeks or 5-fluorouracil (500mg/m), doxorubicin (50mg/m) and cyclophosphamide (500mg/m) every three weeks as adjuvant treatment. The two chemotherapy regimens were compared in term of disease free survival (DFS) and overall survival (OS). Results At a median follow-up of 30 month, the median estimated rate of DFS for patients in the TAC group was 24 month compared to 20 month for patients in the FAC group which was statistically significant (95 % confidence interval [CI], 0.49 to 7.17, P <0.04).In terms of OS, no significant difference between the two treatment groups, the median estimated rate of OS in the TAC arm was 25 month compared to 24 month in the FAC arm ( CI, 2.84 to 5.27, P= 0.522).No significant difference in DFS as regardingthe prognostic factors as number of involved axillary lymph nodes (p=0.485), menopausal status (P=0.684), hormone-receptor status (P=0.795) and HER2/neustatus (P=0.509). The incidence of grade 2-3 anemia was higher in the TAC group than in the FAC group (23.3 % versus 13.3 %, P<0.04). As regarding neutropenia, it occurred more frequently in the TAC group (13.3 % versus 6.7 %, P<0.04). The incidence of grade 3 febrile neutropenia in the TAC group was 10 % versus 3.3 % in the FAC group (P=0.372). Conclusion Incorporation of docetaxel in the adjuvant treatment of early node-positive breast cancer patients improves the DFS with tolerable toxicity compared to FAC regimen. However, further follow-up is needed to demonstrate its effect on the OS.

Keywords: TAC/FAC, adjuvant, node-positive, breast cancer, survival

Edition: Volume 6 Issue 9, September 2017

Pages: 59 - 64


How to Cite this Article?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid, "Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20176407, Volume 6 Issue 9, September 2017, 59 - 64

32 PDF Views | 39 PDF Downloads

Download Article PDF



Similar Articles with Keyword 'adjuvant'

Research Paper, Oncology Science, India, Volume 6 Issue 8, August 2017

Pages: 1570 - 1576

A Randomised Trial of Neoadjuvant Chemotherapy in Locally Advanced Oral Cancers

Dr. Sivakumari Sivarajan, Dr. Kavitha Sukumar, Dr. Anitha.G

Share this article

Case Studies, Oncology Science, India, Volume 7 Issue 6, June 2018

Pages: 1216 - 1218

Primary Angiosarcoma of Breast in Elderly Woman

Kanmani Velarasan.S, Deivanayagam Ramasundaram

Share this article

Case Studies, Oncology Science, India, Volume 7 Issue 4, April 2018

Pages: 1075 - 1077

Definitive Radiotherapy for Vaginal Angiomyofibroblastoma

Dr Rashmi S, Dr Vaishnavi P Reddy, Dr Kiran Kumar B R, Dr Sanjeet K Mandal

Share this article

Research Paper, Oncology Science, Egypt, Volume 6 Issue 9, September 2017

Pages: 59 - 64

Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid

Share this article

Research Paper, Oncology Science, India, Volume 7 Issue 12, December 2018

Pages: 1323 - 1325

Effect of Hysterectomy on Volume of Bowel Irradiated in Gynaecological Malignancies: A Comparative Dosimetric Study

Chaitra M Deshpande, Venkataraman Kini, K Kamalaksh Shenoy, Avin Kumar, Kavitha

Share this article



Similar Articles with Keyword 'breast cancer'

Research Paper, Oncology Science, Egypt, Volume 6 Issue 6, June 2017

Pages: 2808 - 2814

In-Vitro Assessment of Anticancer Potential of Lapatinab and Bee Venom against Breast (MCF-7) and Prostate (PC-3) Cancer Cell Lines: In-Vitro Study

N. Karem, A. Fahmy

Share this article

Research Paper, Oncology Science, Iraq, Volume 6 Issue 8, August 2017

Pages: 638 - 642

Determination of HER2 Gene Amplification using Chromogenic in Situ Hybridization (CISH) in Iraqi Patients with Breast Carcinoma

Basim Mohammed Khashman, Safana Abdul-Sattar

Share this article

Research Paper, Oncology Science, India, Volume 5 Issue 11, November 2016

Pages: 651 - 653

Effect of Various Variables of Demographic and Life Style on Menopausal Women by Neural Network

Meenakshi Gahlot, Bharti Prakash

Share this article

Research Paper, Oncology Science, Egypt, Volume 6 Issue 9, September 2017

Pages: 59 - 64

Which is More Effective; Docetaxel, Doxorubicin and Cyclophosphamide Or 5-Fluorouracil, Doxorubicin and Cyclophosphamide in Adjuvant Treatment of Early Stage Node Positive Breast Cancer?

Rehab F Mohamed, Abeer F Amin, Mohamed Alaa Elden Hassan Mohamed, Rania A Abdelhamid

Share this article

Survey Paper, Oncology Science, India, Volume 6 Issue 9, September 2017

Pages: 1026 - 1029

Acceptability of Community Women in Rural Area for Ca Cervix and Ca Breast Screening

Sunita H. Tata, A. Pratinidhi, Radhika Joshi, V. Whaval, S. Kakade

Share this article



Similar Articles with Keyword 'survival'

Research Paper, Oncology Science, Egypt, Volume 6 Issue 7, July 2017

Pages: 1502 - 1509

P16 Expression Independent of Human Papilloma Virus in Egyptian Patients with Head and Neck Squamous Cell Carcinoma: A Retrospective Study

Dina RD. Ibrahim, Reham M. Faheim, Mohamed R. Kelany, Nahla M. Awad, Hala M. El-Sallaly, Nashwa N. El-Khazragy

Share this article

Research Paper, Oncology Science, India, Volume 6 Issue 8, August 2017

Pages: 1570 - 1576

A Randomised Trial of Neoadjuvant Chemotherapy in Locally Advanced Oral Cancers

Dr. Sivakumari Sivarajan, Dr. Kavitha Sukumar, Dr. Anitha.G

Share this article

Research Paper, Oncology Science, India, Volume 6 Issue 12, December 2017

Pages: 1572 - 1577

Prognostic Significance of Ratio of Metastatic Lymph Nodes (MLNR) to Total Lymph Nodes Harvested in Squamous Cell Carcinoma of Esophagus

Vikas Sharma, S Krishnamurthy

Share this article

Research Paper, Oncology Science, Italy, Volume 6 Issue 3, March 2017

Pages: 1121 - 1125

Incidence and Outcomes of Bone Metastases. Evaluation of BTAs Therapy, Pain Relief and Quality of Life: Experience from a Single Cancer Center

Claudia Garipoli, Elisabetta Alafaci, Iman Komaei

Share this article

Case Studies, Oncology Science, India, Volume 8 Issue 6, June 2019

Pages: 2310 - 2312

An Unusual Case of Cervical Leiomyosarcoma with Uterine Prolapse: A Case Report

Dr. Varsha Maran, Dr. Nandita Maitra, Dr. Purvi Patel, Dr. Tosha Sheth, Dr. Palak Vaishnav

Share this article
Top